Literature DB >> 19076359

Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.

Kaleeckal G Harikumar1, Laurence J Miller.   

Abstract

Oligomeric complexes of G protein-coupled receptors (GPCRs) are now commonly recognized and can provide a mechanism for regulation of signaling systems. Receptor oligomerization has been most extensively studied using coimmunoprecipitation and bioluminescence or fluorescence resonance energy-transfer techniques. Here, we have utilized decay of time-resolved fluorescence anisotropy of yellow fluorescent protein-labeled cholecystokinin receptor constructs to examine the state of oligomerization of this receptor in living cells. The rotational correlation times established that the cholecystokinin receptor is constitutively present in an oligomeric state that is dissociated in response to agonist occupation. In contrast, antagonist occupation failed to modify this signal, leaving the oligomeric structure intact. This dynamic technique complements the other biochemical and steady-state fluorescence techniques to establish the presence of oligomeric receptor complexes in living cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076359      PMCID: PMC3580951          DOI: 10.1196/annals.1418.004

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer.

Authors:  Z J Cheng; L J Miller
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

Review 2.  G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.

Authors:  Gerda E Breitwieser
Journal:  Circ Res       Date:  2004-01-09       Impact factor: 17.367

Review 3.  Dimerization of G-protein-coupled receptors: roles in signal transduction.

Authors:  Mei Bai
Journal:  Cell Signal       Date:  2004-02       Impact factor: 4.315

4.  Global analysis of biochemical and biophysical data.

Authors:  J M Beechem
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Delia I Pinon; William S Wessels; Franklyn G Prendergast; Laurence J Miller
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

8.  Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.

Authors:  Sonia Terrillon; Claude Barberis; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

9.  Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).

Authors:  S P Powers; D Fourmy; H Gaisano; L J Miller
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

10.  Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth.

Authors:  Zhi-Jie Cheng; Kaleeckal G Harikumar; Eileen L Holicky; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

View more
  1 in total

Review 1.  Contributions of fluorescence techniques to understanding G protein-coupled receptor dimerisation.

Authors:  Alan D Goddard; Anthony Watts
Journal:  Biophys Rev       Date:  2012-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.